And patent protections will keep low-cost generics off the market for at least two decades
CagriSema has a very nice efficacy in that regard in type 2 diabetes
Prescription GLP-1 medications are required to undergo extensive pre-market testing, including studies on absorption, metabolism, interactions, and long-term safety
Together, these therapies provide a science-based approach to total wellness, helping you feel stronger, more energized, and fully supported in your long-term health journey
It can be used as both injection-type or oral-type drug.[9] The marketing authorization in EU was granted on 8 February 2018.[10] It is still under review by regulatory authorities in Japan, pending approval.[11] ------------------------------------- Reported by Jules Levin AASLD 2018 Nov 9-13 SF Philip N Newsome1 ,2, Stephen A Harrison3, Sren Rasmussen4, Tea Monk Fries4, Luc Van Gaal5 1National Institute for Health Research Birmingham Biomedical Research Centre and Liver Unit at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
